Kimberly Struble, PharmD

Biography

Dr. Kimberly Struble is currently a Medical Team Leader in the Division of Antivirals at the Food and Drug Administration. She received a baccalaureate of Science in Pharmacy from the University of Connecticut and a Doctor of Pharmacy from the University of Arkansas for Medical Sciences.

She joined FDA in October 1993 and served in various positions as a project manager and clinical reviewer. She left FDA in March 2002 to a pharmaceutical company and rejoined FDA in May 2003. During her career, she has been involved in all phases of clinical drug development and leads a team responsible for the development of new products for the treatment and prevention of HIV infection, hepatitis B and C, influenza, various herpes infections, COVID-19 and other emerging viral infections.  She is a member of the Department of Health and Human Services HIV Treatment Guidelines Panel. She serves on various committees including the Forum for Collaborative Research, Long Acting/ Extended Release Antiretroviral Research Resource Program and is the FDA representative to CDC for occupational post-exposure prophylaxis public health service working group. She has over 35 publications and 100 presentations relating to antiviral development and FDA regulations.

Struble, Kimberly 2024
Position
Food and Drug Administration, United States